RNASE2 has been shown to regulate the production of cytokines (e.g., Interleukin-4 (IL-4) and Interleukin-10 (IL-10)), which can modulate the immune response and promote an immunosuppressive microenvironment, allowing tumor cells to escape immune surveillance [20]. The gene discussed is IL10; the disease is neoplasm.